MDCX

Medicus Pharma

--(--)

Market Open: --

--(--)

Post-Market: --

Key Stats

--DAY`S RANGE--

--52 WK RANGE--

Open

Prev.Close

%Range

Turnover

Avg Vol(4W)

Market Cap

Div.Yield

P/E(TTM)

EPS(TTM)

Beta

Free Float

Shares Outstanding

%Turnover

P/E(DYN)

P/B

BVPS

High

Low

52 Week High

52 Week Low

About MDCX

Medicus Pharma Ltd.

A biotechnology and life science company focused on accelerating clinical development plans for new and disruptive therapeutic assets

Industry

Biological Technology

Established Date

04/30/2008

Listing Date

11/14/2024

Exchange

NASDAQ Stock Exchange

Full-time Employees

Fiscal Year Ends

12-31

Website

www.medicuspharma.com

Security Type

Common stock

Office address

Suite 3400 - 100 King St W, Toronto, ON M5X 1A4, Canada

Business

Introduction

Medicus Pharma Ltd., was incorporated on April 30, 2008 under the laws of the province of Ontario, Canada. They are a biotechnology and life sciences company focused on accelerating clinical development programs for new and disruptive therapeutic assets. Currently, they are developing a product, SkinJectTM, for the treatment of basal cell carcinoma. Through its wholly-owned subsidiary SkinJect, Inc., they are focused on developing their licensed drug-device portfolio products for the treatment of non-lanoma skin cancer using novel dissolvable microneedle arrays. Their joint product candidate is doxorubicin tip-loaded D-MNA submitted to the U.S. Food and Drug Administration (" FDA ") under a new drug research application, regulated by the Center for Drug Evaluation and Registry in Oncology (CDER).